Fredun Pharmaceuticals Net Profit Rises 64% YoY in Q1 FY26

Fredun Pharmaceuticals Limited, a leading pharmaceuticals formulation manufacturing company in India, has reported a 64% YoY rise in net profit for Q1 FY26. The company's total income has also increased by 52.08% YoY. The company's diversified portfolio across domestic and international markets, including generics, cosmeceuticals, nutraceuticals, mobility and animal healthcare products, has contributed to this growth. The company has entered the organized pet care market with the acquisition of a controlling stake in One Pet Stop through its subsidiary FRPL. The pharmaceutical and healthcare industry continues to see robust demand, and Fredun Pharmaceuticals is well-positioned to capitalize on these opportunities.